Product Images Tizanidine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Tizanidine NDC 70934-811 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 70934 811 30 Master Bottle Label Approval Rev A 01 21

Label - 70934 811 30 Master Bottle Label Approval   Rev A 01 21

This is a medicine with NDC number 70934-811-30. It is in the form of tablets containing 4mg Tizanidine as an active ingredient. The package contains 30 tablets. The remaining text is not readable and contains a few non-English characters.*

fig1 - fig1

fig1 - fig1

This is a table showing the plasma tizanidine concentration in ng/mL for different dosages and timings. The table includes data for 4mg tizanidine tablets and capsules, taken with or without food at different hours from dosing. No additional information is available.*

fig2 - fig2

fig2 - fig2

The text appears to be a graph or a table without any further details. It is not possible to generate a useful description with this information.*

fig3 - fig3

fig3 - fig3

The text describes an improvement in Ashworth score using a medication called Zanidine at a mean dose of 28.6 mg. It is unclear what condition or disease is being treated. The improvement is evaluated at Study Week 3 and the end of maintenance endpoint is at Study Week 7 using last observation carried forward.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.